5278.KLSE Rhone Ma Holdings Bhd

Healthcare Pharmaceuticals Kuala Lumpur Exchange
Add to portfolio Ask AI about 5278.KLSE
0.6850 MYR
Close of Oct 29, 2026
0.6107 0.7093
Market cap
MYR 152M
P/E
11.4x
P/B
0.82x
ROE
7.7%
Dividend yield
3.67%
Fundamental score
3.6/5

Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Jun 2026.

Is 5278.KLSE undervalued?

Graham number
Price0.6850
Graham value1.06
Discount35.3%

5278.KLSE trades 35.3% below its Graham number.

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Rhone Ma Holdings Bhd fundamental analysis

18 of 22 checks passed

ROE 0/2

Low return on equity (7.7%), below 10%.

ROA 0/1

Return on assets (5.5%) is below the industry median (5.5%).

Profit Consistency 2/2

Profitable for 10 consecutive years.

Earnings Growth 5Y 1/1

Earnings per share grew over the past 5 years.

Earnings Acceleration 1/1

Last year's EPS growth (15.6%) is above the 5-year average (12.1% a year).

Earnings Growth vs Industry 0/1

Last year's EPS growth (15.6%) is below the industry median (15.6%).

Revenue Growth 1/2

Revenue grew 4.1% a year over the past 3 years.

Short-term Liquidity 1/1

Current assets cover short-term liabilities.

Long-term Liabilities 1/1

Current assets cover long-term liabilities.

Debt to Equity 2/2

Low debt to equity (7.6%), 40% or less.

Debt Trend 1/1

Debt to equity has not risen over the past 5 years.

Debt Coverage 1/1

Operating cash flow covers 20% of total debt.

Interest Coverage 1/1

EBIT is 20.6x against interest expense, well covered.

PE vs Market 0/1

PE (11.4x) is above the market median (11.4x).

PE vs Industry 1/1

PE (11.4x) is below the industry median (16.6x).

PBV 1/1

Price to book (0.8x) is below the industry median (0.9x).

Graham Number 1/1

The price is below the Graham number (PE x PB = 9.4, limit 22.5).

PEG 1/1

PEG on 5-year earnings growth is 0.94, growth is cheap.

Dividend Yield 1/2

Dividend yield (3.7%) is above the bottom 25% of dividend payers in the market.

Dividend Stability 1/2

Dividends paid without a cut of more than 10% for 6 years.

Dividend Growth 1/1

Dividends paid grew over the past 5 years.

Payout Ratio 1/1

Payout ratio is 39.3%, covered by earnings.

Each check is worth 1 or 2 points by how much it says about the quality of the company. The score is the share of points earned, out of 5. Ask AI to explain this score

About Rhone Ma Holdings Bhd

Rhone Ma Holdings Berhad, an investment holding company, engages in the manufacture, trading, marketing, and distribution of biotechnology and animal health products primarily in Malaysia. The company operates through Animal Health Products and Food Equipment; Food Ingredients; and others segments. It offers diagnostic laboratory analysis and consultation services to veterinary, agriculture, and food industries; tests and diagnostics services for human healthcare; and veteri…

Full company profile